Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK PHARMA GLENMARK PHARMA GSK PHARMA/
GLENMARK PHARMA
 
P/E (TTM) x 62.2 -31.4 - View Chart
P/BV x 18.9 2.9 661.0% View Chart
Dividend Yield % 1.6 0.3 630.7%  

Financials

 GSK PHARMA   GLENMARK PHARMA
EQUITY SHARE DATA
    GSK PHARMA
Mar-23
GLENMARK PHARMA
Mar-23
GSK PHARMA/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs1,684487 345.6%   
Low Rs1,231349 352.7%   
Sales per share (Unadj.) Rs191.9460.4 41.7%  
Earnings per share (Unadj.) Rs35.913.4 268.2%  
Cash flow per share (Unadj.) Rs39.835.0 113.4%  
Dividends per share (Unadj.) Rs32.002.50 1,280.0%  
Avg Dividend yield %2.20.6 367.2%  
Book value per share (Unadj.) Rs102.9335.1 30.7%  
Shares outstanding (eoy) m169.41282.17 60.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.60.9 836.1%   
Avg P/E ratio x40.631.3 130.0%  
P/CF ratio (eoy) x36.711.9 307.3%  
Price / Book Value ratio x14.21.2 1,135.5%  
Dividend payout %89.218.7 477.3%   
Avg Mkt Cap Rs m246,858117,953 209.3%   
No. of employees `000NANA-   
Total wages/salary Rs m5,95027,810 21.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m32,517129,901 25.0%  
Other income Rs m1,0073,168 31.8%   
Total revenues Rs m33,524133,069 25.2%   
Gross profit Rs m8,03315,125 53.1%  
Depreciation Rs m6586,113 10.8%   
Interest Rs m183,496 0.5%   
Profit before tax Rs m8,3648,685 96.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2884,911 46.6%   
Profit after tax Rs m6,0763,774 161.0%  
Gross profit margin %24.711.6 212.2%  
Effective tax rate %27.456.5 48.4%   
Net profit margin %18.72.9 643.2%  
BALANCE SHEET DATA
Current assets Rs m24,94398,737 25.3%   
Current liabilities Rs m13,26450,455 26.3%   
Net working cap to sales %35.937.2 96.6%  
Current ratio x1.92.0 96.1%  
Inventory Days Days977 1,452.5%  
Debtors Days Days216115 187.5%  
Net fixed assets Rs m6,98876,920 9.1%   
Share capital Rs m1,694282 600.4%   
"Free" reserves Rs m15,73594,281 16.7%   
Net worth Rs m17,43094,563 18.4%   
Long term debt Rs m038,521 0.0%   
Total assets Rs m31,930175,658 18.2%  
Interest coverage x462.63.5 13,276.6%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.00.7 137.7%   
Return on assets %19.14.1 461.2%  
Return on equity %34.94.0 873.5%  
Return on capital %48.19.2 525.5%  
Exports to sales %00-   
Imports to sales %48.10-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m15,630NA-   
Fx inflow Rs m1,62246,464 3.5%   
Fx outflow Rs m15,63012,712 123.0%   
Net fx Rs m-14,00833,751 -41.5%   
CASH FLOW
From Operations Rs m4,8426,254 77.4%  
From Investments Rs m8,079-5,285 -152.9%  
From Financial Activity Rs m-15,433-775 1,992.5%  
Net Cashflow Rs m-2,512325 -773.1%  

Share Holding

Indian Promoters % 0.0 46.7 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 11.6 34.7 33.4%  
FIIs % 2.9 23.7 12.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 53.4 46.9%  
Shareholders   114,663 209,931 54.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK PHARMA With:   SUN PHARMA    CIPLA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GSK Pharma vs Glenmark Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GSK Pharma vs Glenmark Pharma Share Price Performance

Period GSK Pharma Glenmark Pharma S&P BSE HEALTHCARE
1-Day 3.26% -0.57% 1.18%
1-Month -9.77% 5.16% -0.75%
1-Year 52.63% 112.94% 61.82%
3-Year CAGR 10.89% 27.51% 18.16%
5-Year CAGR 8.44% 8.05% 19.79%

* Compound Annual Growth Rate

Here are more details on the GSK Pharma share price and the Glenmark Pharma share price.

Moving on to shareholding structures...

The promoters of GSK Pharma hold a 75.0% stake in the company. In case of Glenmark Pharma the stake stands at 46.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GSK Pharma and the shareholding pattern of Glenmark Pharma.

Finally, a word on dividends...

In the most recent financial year, GSK Pharma paid a dividend of Rs 32.0 per share. This amounted to a Dividend Payout ratio of 89.2%.

Glenmark Pharma paid Rs 2.5, and its dividend payout ratio stood at 18.7%.

You may visit here to review the dividend history of GSK Pharma, and the dividend history of Glenmark Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.